EDAP Stock Analysis: Buy, Sell, or Hold?
EDAP - EDAP TMS SA
$3.39
-0.14 (-3.97%)
▼
5d:
-10.08%
30d:
-20.24%
90d:
+3.04%
HOLD
MODERATE Confidence
Analysis Updated: Apr 2, 2026 12:00 AM ET
Earnings: May 21, 2026
Get Alerted When EDAP Hits Your Target Price
Join 10,000+ traders who never miss a move
You're in! Check your email to confirm and set your target price.
100% Free
No spam, ever
Unsubscribe anytime
Interactive Price Chart (1 Month)
Loading chart...
Loading historical data...
Bottom Line:
📊 HOLD: EDAP shows balanced signals. Fine to hold or accumulate slowly. Monitor for clearer direction.
📊 HOLD: EDAP shows balanced signals. Fine to hold or accumulate slowly. Monitor for clearer direction.
In-depth Analysis How we analyze
Valuation Analysis: EDAP is currently trading at $3.39, which is considered oversold relative to its 30-day fair value range of $3.70 to $4.32.
Technical Outlook: Technically, EDAP is in a strong uptrend. Immediate support is located at $3.10, while resistance sits at $4.01. Short-term momentum is weak, with the stock down 4.0% recently.
Market Sentiment: EDAP has a weak technical setup (25/100), with bearish trendlines and momentum suggesting caution for short-term entries. Wall Street analysts see significant upside, with an average price target of $6.83 (+101.6%). The stock is fairly positioned - fine to hold existing positions or accumulate slowly on dips, but not an urgent buy.
Technical Outlook: Technically, EDAP is in a strong uptrend. Immediate support is located at $3.10, while resistance sits at $4.01. Short-term momentum is weak, with the stock down 4.0% recently.
Market Sentiment: EDAP has a weak technical setup (25/100), with bearish trendlines and momentum suggesting caution for short-term entries. Wall Street analysts see significant upside, with an average price target of $6.83 (+101.6%). The stock is fairly positioned - fine to hold existing positions or accumulate slowly on dips, but not an urgent buy.
Quick Decision Summary
Current Position
OVERSOLD
Fair Price Range
$3.70 -
$4.32
Company Quality Score
53/100
(HOLD)
Options IV Signal
38th percentile
(NORMAL)
Volume Confirmation
HIGH
Confidence Score
56.2%
All Signals
- BULLISH: Price oversold vs 30-day range
- NEUTRAL: Options fairly priced (IV 38th percentile)
- BEARISH: Weak technical setup (25/100)
- BULLISH: High volume confirmation
- BEARISH: Downward momentum (-4.0%)
- BULLISH: Trading 101.6% below Wall St target ($6.83)
- CAUTION: 5-day price weakness (-10.1%) - monitor closely
Fair Price Analysis
30-Day Fair Range
$3.70 -
$4.32
Current vs Fair Value
OVERSOLD
Expected Move (7 Days)
±$0.52
(15.4%)
Support & Resistance Levels
Support Level
$3.10
Resistance Level
$4.01
Current Trend
Strong Uptrend
Technical data as of
Apr 2, 2026
Fundamental Context
Forward P/E (Next Year Est.)
-5.74
Wall Street Target
$6.83
(+101.6%)
Revenue Growth (YoY)
-19.0%
Earnings Growth (YoY)
-62.2%
Profit Margin
-41.5%
Share & Embed Analysis
Last updated: April 03, 2026 6:25 AM ET
Data refreshes hourly during market hours. Next update: 7:25 AM
Data refreshes hourly during market hours. Next update: 7:25 AM
🔥 Top Stocks Breaking Out Now
| Ticker | Score | Recommendation | Change % |
|---|
Technical Signals Check
Is EDAP showing a specific setup today?
Insider Activity (6 Months)
0
Buys
0
Sells
0
Net
NEUTRAL
Top Rated Medical Distribution Stocks
Top-rated stocks in Medical Distribution by analyst ratings.
| Stock | Analyst Consensus | Analyst Target | Tradestie Score |
|---|---|---|---|
|
CAH
Cardinal Health Inc |
BUY
17 analysts |
$250 | 67 BUY |
|
MCK
McKesson Corporation |
STRONG BUY
17 analysts |
$998 | 53 HOLD |
|
COR
Cencora Inc. |
BUY
17 analysts |
$410 | 56 HOLD |
|
HSIC
Henry Schein Inc |
HOLD
16 analysts |
$90 | 57 HOLD |
|
QIPT
Quipt Home Medical Corp |
STRONG BUY
5 analysts |
$4 | 53 HOLD |
